These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study. Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S; JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445 [TBL] [Abstract][Full Text] [Related]
9. Immediate response to prasugrel loading in patients with ST-elevation myocardial infarction: Predictors and outcome. Koifman E; Beigel R; Herscovici R; Fefer P; Rozenberg N; Sabbag A; Biton Y; Segev A; Shechter M; Asher E; Matetzky S Thromb Res; 2016 Aug; 144():176-81. PubMed ID: 27386796 [TBL] [Abstract][Full Text] [Related]
10. Contemporary use of P2Y Rakowski T; Siudak Z; Dziewierz A; Plens K; Kleczyński P; Dudek D J Thromb Thrombolysis; 2018 Jan; 45(1):151-157. PubMed ID: 29075924 [TBL] [Abstract][Full Text] [Related]
11. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative. Faridi KF; Garratt KN; Kennedy KF; Maddox TM; Secemsky EA; Butala NM; Yeh RW Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006275. PubMed ID: 32156164 [TBL] [Abstract][Full Text] [Related]
12. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684 [TBL] [Abstract][Full Text] [Related]
16. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction. Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458 [TBL] [Abstract][Full Text] [Related]
17. Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial. Welsh RC; Sidhu RS; Cairns JA; Lavi S; Kedev S; Moreno R; Cantor WJ; Stankovic G; Meeks B; Yuan F; Džavík V; Jolly SS Can J Cardiol; 2019 Oct; 35(10):1377-1385. PubMed ID: 31492492 [TBL] [Abstract][Full Text] [Related]
18. Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study. Khan JN; Greenwood JP; Nazir SA; Lai FY; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman D; Peebles C; Wong J; Flather M; Swanton H; Gershlick AH; McCann GP J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27247336 [TBL] [Abstract][Full Text] [Related]
19. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis. Wang Z; Zhou DY; Su Y; Si LY; Xu Q BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of prasugrel and clopidogrel in st-segment elevation myocardial infarction in prehospital setting. Szarpak L; Ruetzler K; Figatowski T; Pruc M; Gasecka A; Jaguszewski MJ Am J Emerg Med; 2022 Mar; 53():254-255. PubMed ID: 33934923 [No Abstract] [Full Text] [Related] [Next] [New Search]